Regulation of protective immunity against Leishmania major in mice

Current Opinion in Immunology

Volumn 10, Issue 4, 1998, Pages 459-464

  Louis, Jacques ^a   Himmelrich, Hayo ^a   Parra Lopez, Carlos ^a   Tacchini Cottier, Fabienne ^a   Launois, Pascal ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOKINE;

ANIMAL MODEL; HELPER CELL; IMMUNE RESPONSE; LEISHMANIA MAJOR; LEISHMANIASIS; MACROPHAGE; MOUSE; NONHUMAN; REVIEW; T LYMPHOCYTE;

EID: 0032145476     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(98)80121-0     Document Type: Article

References (67)

1. Reiner SL, Locksley RM. The regulation of immunity to Leishmania major. Annu Rev Immunol. 13:1995;151-177.
2. Assreuy J, Cunha FQ, Epperlein M, Noronha-Dutra A, O'Donnell CA, Liew FY, Moncada S. Production of nitric oxide and superoxide by activated macrophages and killing of Leishmania major. Eur J Immunol. 24:1994;672-676.
3. + effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major. J Exp Med. 179:1994;1367-1371.
4. + T cell response. J Exp Med. 181:1995;961-971.
5. Wei X-Q, Charles IG, Smith A, Feng G-J, Huang F-P, Xu D, Muller W, Moncada S, Liew FY. Altered immune responses in mice lacking inductible nitric oxide synthase. Nature. 375:1995;408-411.
6. Stenger S, Donhauser N, Thürin H, Röllinghoff M, Bogdan C. Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J Exp Med. 183:1996;1501-1514.
7. of special interest Diefenbach A, Schindler H, Donhauser N, Lorenz E, Laskay T, MacMicking J, Röllinghoff M, Gresser I, Bogdan C. Type 1 Interferon (IFNα/β) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity. 8:1998;77-87 This paper shows that genetic deletion or functionnal inactivation of type 2 nitric oxide synthase abolishes the natural killer cell response seen one day after infection with Leishmania major. Neutralisation of IFNα/β has a similar effect.
8. Huang S, Hendricks W, Althage A, Hemmi S, Bluethmann H, Vilcek J, Zinkernagel RM, Aguet M. Immune response in mice that lack the interferon-γ receptor. Science. 259:1993;1742-1745.
9. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA. Multiple defects of immune cell function in mice with disrupted interferon gamma gene. Science. 259:1993;1739-1742.
10. + T cells. Immunol Rev. 146:1995;223-239.
11. of special interest Conceiçao-Silva F, Hahne M, Schröter M, Louis J, Tschopp J. The resolution of lesions induced by Leishmania major in mice requires a functional Fas (APO-1, CD95) pathway of cytotoxicity. Eur J Immunol. 28:1998;237-245 This paper shows for the first time the requirement of a functional Fas/Fas-ligand pathway of cytotoxicity for the resolution by resistant mice of lesions induced by infection with L. major.
12. Xu D, Chan WL, Leung BP, Huang FP, Wheeler R, Piedrafita D, Robinson JH, Liew FY. Selective expression of a stable cell surface molecule on type 2 but not on type 1 helper T cells. J Exp Med. 187:1998;787-794.
13. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature. 383:1996;787-793.
14. of special interest Ohmori Y, Hamilton TA. IL-4-induced STAT6 suppresses IFN-γ-stimulated STAT1-dependent transcription in mouse macrophages. J Immunol. 159:1997;5474-5482 This paper shows that interferon (IFN)-γ-induced expression of the gene for IFN regulatory factor 1 (IRF-1) is suppressed by IL-4.
15. Paludan SR, Lovmand J, Ellermann-Eriksen S, Mogensen SC. Effect of IL-4 and IL-13 on IFN-gamma induced production of nitric oxide in mouse macrophages infected with herpes simplex virus type 2. FEBS Lett. 414:1997;61-64.
16. Scott P, Trinchieri G. The role of natural killer cells in host-parasite interactions. Curr Opin Immunol. 7:1995;34-40.
17. of outstanding interest Lanier LL. Natural killer cells: from no receptors to too many. Immunity. 6:1997;371-378 This excellent review summarises the current status of knowledge concerning inhibitory receptors on natural killer cells.
18. + T cell subsets and induces early resistance to L. major in mice. J Exp Med. 178:1993;567-577.
19. Duncan GS, Mittrücker H-W, Kägi D, Matsuyama T, Mak TW. The transcription factor interferon regulatory factor-1 is essential for natural killer cell function in vivo. J Exp Med. 184:1996;2043-2048.
20. of special interest Taki S, Sato T, Ogasawa K, Fukuda T, Sato M, Suzuki G, Mitsuyama M, Shin EH, Taniguchi T, Asano Y. Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity. 6:1997;673-679 This paper shows for the first time the in vitro importance of interferon regulatory factor 1 (IRF-1) in the regulation of Th1 responses.
21. of special interest Lohoff M, Ferrick D, Mittrücker H-W, Duncan GS, Bischof S, Röllinghoff M, Mak TW. Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo. Immunity. 6:1998;681-689 This paper shows the in vivo importance of IRF-1 in the regulation of Th1 responses using the murine model of Leishmania major.
22. Afonso LCC, Sharton TM, Vieira LQ, Wysocka M, Trinchieri G, Scott P. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science. 263:1994;235-237.
23. Scharton-Kersten T, Afonso LCC, Wysocka M, Trinchieri G, Scott P. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J Immunol. 154:1995;5320-5330.
24. Campbell KA, Ovendale PJ, Kennedy MK, Fanslow WC, Reed SG, Maliszewski CR. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity. 4:1996;283-289.
25. Kamanaka M, Yu P, Yasui T, Yoshida K, Kawabe T, Horii T, Kishimoto T, Kikutani H. Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity. 4:1996;275-281.
26. Soong L, Xu J-C, Grewa LIS, Kima P, Sun J, Longley BJ, Ruddle NH, McMahon-Pratt D, Flavell RA. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity. 4:1996;263-273.
27. Brown JA, Titus RG, Nabavi N, Glimcher LH. Blockade of CD86 ameliorates Leishmania major infection by down regulating the Th2 response. J Infec Dis. 147:1996;1303-1308.
28. Brown DR, Green JM, Moskowitz NH, Davis M, Thompson CB, Reiner SL. Limited role of CD28-mediated signals in T helper subset differenciation. J Exp Med. 184:1996;803-810.
29. of outstanding interest Fowell DJ, Magram J, Turck CW, Killeen N, Locksley RM. Impaired Th2 subset development in the absence of CD4. Immunity. 6:1997;559-569 An interesting study demonstrating the importance of the CD4 molecule in Th2 cell development.
30. of outstanding interest Brown DR, Moskowitz NH, Killeen N, Reiner SL. A role of CD4 in peripheral T cell differentiation. J Exp Med. 186:1997;101-107 This paper demonstrates the importance of the CD4 molecule in Th2 cell development.
31. O'Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity. 8:1998;275-283.
32. Kohno K, Kataoka J, Ohtsuki T, Suemoto Y, Okamoto I, Usui M, Ikeda M, Kurimoto M. IFN-γ inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. J Immunol. 158:1997;1541-1550.
33. of outstanding interest Robinson D, Shibuya K, Mui A, Zonin F, Murphy E, Sana T, Hartley SB, Menon S, Kastelein R, Bazan F, O'Garra A. IGIF does not drive Th1 development but synergizes with IL-12 for IFN-γ production and activates IRAK and NF-κB. Immunity. 7:1997;571-581 This paper shows that IL-18 does not by itself induce Th1 cell development but acts in synergy with IL-12, activating the IL-1-receptor-associated kinase (IRAK) transcription factor.
34. Shibuya K, Robinson D, Zonin F, Hartley SB, Macatonia SE, Somoza C, Hunter CA, Murphy KM, O'Garra A. IL-1α and TNF-α are required for IL-12-induced development of Th1 cells producing high levels of IFN-γ in BALB/c but not C57BL/6 mice. J Immunol. 160:1998;1708-1716.
35. Takeda K, Tsutsui H, Yoshimoto T, Adachi O, Yoshida N, Kishimoto T, Okamura H, Nakanishi K, Akira S. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity. 8:1998;383-390.
36. Kopf M, Brombacher F, Kölher G, Kienzle G, Widmann K-H, Lefrang K, Humborg C, Ledermann B, Solbach W. IL-4 deficient BALB/c mice resist infection with Leishmania major. J Exp Med. 184:1996;1127-1136.
37. -. Eur J Immunol. 25:1995;3298-3307.
38. + T cells in a Th2 response and in immunoglobulin E production. Science. 270:1995;1845-1847.
39. + T cells that promptly produce interleukin 4. Proc Natl Acad Sci USA. 92:1995;11931-11934.
40. + T cells are not essential for T helper cell 2 immune responses. J Exp Med. 184:1996;1295-1304.
41. - T cell population. J Immunol. 157:1996;4421-4427.
42. + T cells recognising a specific epitope of the Leishmania-activated C kinase (LACK) antigen of L. major produces IL-4 very rapidly in response to infection. The importance of these cells in Th2 cell development and susceptibility to infection is clearly demonstrated.
43. Mougneau E, Altare F, Wakil AE, Zheng S, Coppola T, Wang ZE, Waldmann R, Locksley RM, Glaichenhaus N. Expression cloning of a protective Leishmania antigen. Science. 268:1995;563-566.
44. + T cells. It is related to reference [58].
45. Julia V, Rassoulzadegan M, Glaichenhaus N. Resistance to Leishmania major induced by tolerance to a single antigen. Science. 274:1996;421-423.
46. Heinzel FP, Rerko RM, Ahmed F, Pearlman E. Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating Leishmaniasis in normally resistant mice. J Immunol. 155:1995;730-739.
47. Magram J, Connaughton SE, Warrier RR, Carvajal DM, Wu C-Y, Ferrante J, Stewart C, Sarmiento Y, Faherty DA, Gately MK. IL-12-deficient mice are defective in IFN-γ production and type 1 cytokine responses. Immunity. 4:1996;471-481.
48. Mattner F, Magram J, Ferrante J, Launois P, Di Padova K, Behin R, Gately MK, Louis JA, Alber G. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur J Immunol. 26:1996;1553-1559.
49. Heinzel FP, Schoenhaut DS, Rerko RM, Rosser LE, Gately MK. Recombinant interleukin 12 cures mice infected with Leishmania major. J Exp Med. 177:1993;1505-1509.
50. Sypek JP, Chung CL, Mayor SEH, Subramanyam SJ, Goldman SJ, Sieburth DS, Wolf SF, Schaub RG. Resolution of cutaneous leishmaniasis: interleukin 12 iniates a protective T helper type 1 immune response. J Exp Med. 177:1993;1797-1802.
51. Wang ZE, Zheng S, Corry DB, Dalton DK, Seder RA, Reiner SL, Locksley RM. Interferon gamma-independent effects of interleukin 12 administered during acute or established infection due to Leishmania major. Proc Natl Acad Sci USA. 91:1994;12932-12936.
52. + T cells during initiation of infection. J Exp Med. 179:1994;447-456.
53. Vieira LQ, Hondowicz BD, Afonso LCC, Wysocka M, Trinchieri G, Scott P. Infection with Leishmania major induces interleukin-12 production in vivo. Immunol Lett. 40:1994;157-161.
54. of special interest Sutterwala FS, Noel GJ, Clynes R, Mosser DM. Selective suppression of interleukin-12 induction after macrophage receptor ligation. J Exp Med. 185:1997;1977-1985 This paper shows that ligation of some receptors on the surface of macrophages results in impaired IL-12 production.
55. of special interest Marth T, Kelsall BL. Regulation of interleukin-12 by complement receptor 3 signaling. J Exp Med. 185:1997;1987-1995 This paper could provide a basis for the inhibition of IL-12 production by macrophages infected with Leishmania.
56. Carrera L, Gazzinelli RT, Badolato R, Hieny S, Müller W, Kühn R, Sacks DL. Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J Exp Med. 183:1996;515-526.
57. Hsieh CS, Macatonia SE, O'Garra A, Murphy KM. T cell genetic background determines default T helper phenotype development in vitro. J Exp Med. 181:1995;713-721.
58. Guler ML, Gorham JD, Hsieh CS, Mackey AJ, Steen RG, Dietrich WF, Murphy KM. Genetic susceptibility to Leishmania: IL-12 responsiveness in Th1 cell development. Science. 271:1996;984-987.
59. Szabo SJ, Jacobson NG, Dighe AS, Gübler U, Murphy KM. Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity. 2:1995;665-675.
60. Gorham JD, Güler ML, Steen RG, Mackey AA, Daly MJ, Frederick K, Dietrich WF, Murphy KM. Genetic mapping of a murine locus controlling development of T helper 1/T helper 2 type responses. Proc Natl Acad Sci USA. 93:1996;12467-12472.
61. Presky DH, Yang H, Minetti LJ, Chu AO, Nabavi N, Wu C-Y, Gately M, Gübler U. A functional interleukin 12 receptor complex is composed of two β-type cytokine receptor subunits. Proc Natl Acad Sci USA. 93:1996;14002-14007.
62. + T cells differentiating towards the Th2 phenotype in vitro.
63. + T cells from αβ TCR transgenic mice: IL-12 substitution for macrophages to stimulate IFN-γ production is IFN-γ dependent. Int Immunol. 5:1993;1119-1128.
64. + T cells from T cell receptor transgenic mice. J Exp Med. 176:1992;1091-1098.
65. + T cells to enhance priming for inteferon-γ production and diminishes interleukin-4 inhibition of such priming. Proc Natl Acad Sci USA. 90:1993;10188-10192.
66. of outstanding interest Beebe A, Mauze S, Schork NJ, Coffman RL. Serial backcross mapping of multiple loci associated with resistance to Leishmania major in mice. Immunity. 6:1997;551-557 This provides an interesting genetic analysis which has led to the identification of six loci related to resistance to infection with L. major. It is noteworthy that none of these loci, individually, was sufficient for the expression of a resistant phenotype.
67. Roberts LJ, Badwin TM, Curtis JM, Handman E, Foote SJ. Resistance to Leishmania major is linked to the H2 region on chromosome 17 and chromosome 9. J Exp Med. 185:1997;1705-1710.